MRK · 10-Q · 2026Q2 · Full report

Headcount / Restructuring

Merck & Co., Inc. · 2026-08-07 · Importance 64 · Surprise 42

Merck’s 2025 Restructuring Program will eliminate selected sales, administrative, and R&D positions, reduce the global real-estate footprint, and optimize the manufacturing network. The program is expected to be largely completed by the end of 2027, except for certain manufacturing actions expected to conclude by the end of 2029. Merck estimates approximately $3.0 billion of pretax implementation costs, about 60% cash, and expects approximately $1.7 billion of annual savings substantially realized by the end of 2027. The separate 2024 Restructuring Program is expected to cost approximately $4.0 billion and produce approximately $750 million of cumulative annual net savings by the end of 2031.